Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
38,99 USD | +4,22 % | +4,00 % | -15,35 % |
Resumen de negocios
Número de empleados: 255
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Ian Mortimer
CEO | Chief Executive Officer | 48 | 21/10/13 |
Sherry Aulin
DFI | Director of Finance/CFO | 41 | 01/01/11 |
Chief Tech/Sci/R&D Officer | 53 | 23/08/21 | |
Sheila M. Grant
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/20 |
Jodi Regts
IRO | Public Communications Contact | - | 01/12/15 |
Corporate Officer/Principal | 45 | 17/08/20 | |
Andrea DiFabio
LAW | General Counsel | 55 | 07/11/22 |
James Empfield
PRN | Corporate Officer/Principal | - | 01/02/16 |
Corporate Officer/Principal | 63 | 01/03/01 | |
Human Resources Officer | 64 | 17/09/19 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Clarence Machado
BRD | Director/Board Member | 60 | 05/11/20 |
Justin Gover
BRD | Director/Board Member | 53 | 08/08/23 |
Gary Patou
BRD | Director/Board Member | 65 | 01/01/04 |
Steven Gannon
BRD | Director/Board Member | 62 | 21/05/15 |
Ian Mortimer
CEO | Chief Executive Officer | 48 | 21/10/13 |
Dawn Svoronos
BRD | Director/Board Member | 70 | 27/09/16 |
Director/Board Member | 66 | 03/06/21 | |
Gillian Cannon
BRD | Director/Board Member | 60 | 08/08/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 75 468 883 | 74 291 475 ( 98,44 %) | 0 | 98,44 % |
Información de la empresa
Xenon Pharmaceuticals, Inc.
3650 Gilmore Way Suite 200
V5G 4W8, Burnaby
+604 484 3300
http://www.xenon-pharma.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-15,35 % | 2942,53 M | |
+15,20 % | 121 mil M | |
+19,67 % | 113 mil M | |
+18,95 % | 26,02 mil M | |
-23,86 % | 19,39 mil M | |
-19,03 % | 15,91 mil M | |
-20,90 % | 15,09 mil M | |
-46,14 % | 15,06 mil M | |
+63,85 % | 14,93 mil M | |
+4,49 % | 13,85 mil M |
- Bolsa de valores
- Acciones
- Acción XENE
- Empresa Xenon Pharmaceuticals Inc.